E.A., S.J. Withrow, R.L. Page, et al. 1988. Ureterocolonic anastomosis in ten dogs with transitional cell carcinoma. Vet Surg 17:147–153.
662 Straw, R.C., R.A. Lecouteur, B.E. Powers, et al. 1989. Multilobular osteochondrosarcoma of the canine skull: 16 cases (1978–1988). J Am Vet Med Assoc 195:1764–1769.
663 Straw, R.C., S.J. Withrow, E.B. Douple, et al. 1994. The effects of cisdiamminedichloroplatinum II released from D,L,‐polylactic acid implanted adjacent to cortical allografts in dogs. J Orthop Res 12:871–877.
664 Straw, R.C., S.J. Withrow, and B.E. Powers. 1991a. Primary Osteosarcoma of the ulna in 12 dogs. J Am Anim Hosp Assoc 27:323–326.
665 Straw, R.C., S.J. Withrow, and B.E. Powers. 1992. Partial or total hemipelvectomy in the management of sarcomas in nine dogs and two cats. Vet Surg 21:183–188.
666 Straw, R.C., S.J. Withrow, S.L. Richter, et al. 1991b. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med 5:205–210.
667 Sun, F., J. Hernandez, J. Ezquerra, et al. 2002. Angiographic study and therapeutic embolization of soft‐tissue fibrosarcoma in a dog: Case report and literature. J Am Anim Hosp Assoc 38:452–457.
668 Swann, H.M. and D.E. Holt. 2002. Canine gastric adenocarcinoma and leiomyosarcoma: A retrospective study of 21 cases (1986–1999) and literature review. J Am Anim Hosp Assoc 38:157–164.
669 Swiderski, J. and S. Withrow. 2009. A novel surgical stapling technique for rectal mass removal: A retrospective analysis. J Am Anim Hosp Assoc 45:67–71.
670 Szivek, A., R.E. Burns, B. Gericota, et al. 2012. Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993–2007. Vet Comp Oncol 10:65–73.
671 Taeymans, O., D.G. Penninck, and R.M. Peters. 2013. Comparison between clinical, ultrasound, CT, MRI, and pathology findings in dogs presented for suspected thyroid carcinoma. Vet Radiol Ultrasound 54:61–70.
672 Takahashi, M., H. Tomiyasu, E. Hotta, et al. 2014. Clinical characteristics and prognostic factors in dogs with histiocytic sarcomas in Japan. J Vet Med Sci 76:661–666.
673 Tan‐Coleman, B., J. Lyons, C. Lewis, et al. 2013. Prospective evaluation of a 5 x 4 Gy prescription for palliation of canine nasal tumors. Vet Radiol Ultrasound 54:89–92.
674 Tater, G., N. Eberle, S. Hungerbuehler, et al. 2012. Ventricular fractional shortening in 108 dogs with malignant lymphoma undergoing chemotherapy with a cyclic combination protocol including doxorubicin. Tierarztl Prax Ausg K Kleintiere Heimtiere 40:261–266.
675 Taylor, F., R. Gear, T. Hoather, et al. 2009. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. J Small Anim Pract 50:284–289.
676 Taylor, C.W. and S. Kumar. 2005. The effect of immediate breast reconstruction on adjuvant chemotherapy. Breast 14:18–21.
677 Tellado, M.N., F.H. Maglietti, S.D. Michinski, et al. 2020. Electrochemotherapy in treatment of canine oral malignant melanoma and factors influencing treatment outcome. Radiol Oncol 54:68–78.
678 Tepper, L.C., I.B. Spiegel, and G.J. Davis. 2011. Diagnosis of erythema multiforme associated with thymoma in a dog and treated with thymectomy. J Am Anim Hosp Assoc 47:e19–e25.
679 Thamm, D.H., E.A. Mauldin, and D.M. Vail. 1999. Prednisone and vinblastine chemotherapy for canine mast cell tumor‐‐41 cases (1992–1997). J Vet Intern Med 13:491–497.
680 Thamm, D.H., M.M. Turek, and D.M. Vail. 2006. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high‐risk canine mast cell tumour: 61 cases. J Vet Med Sci 68:581–587.
681 Theon, A.P., P.Y. Barthez, B.R. Madewell, et al. 1994. Radiation therapy of ceruminous gland carcinomas in dogs and cats. J Am Vet Med Assoc 205:566–569.
682 Theon, A.P., B.R. Madewell, M.F. Harb, et al. 1993. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs. J Am Vet Med Assoc 202:1469–1475.
683 Theon, A.P., B.R. Madewell, A.S. Moore, et al. 1991. Localized thermo‐cisplatin therapy: A pilot study in spontaneous canine and feline tumours. Int J Hyperthermia 7:881–892.
684 Theon, A.P., S.L. Marks, E.S. Feldman, et al. 2000. Prognostic factors and patterns of treatment failure in dogs with unresectable differentiated thyroid carcinomas treated with megavoltage irradiation. J Am Vet Med Assoc 216:1775–1779.
685 Theon, A.P., C. Rodriguez, and B.R. Madewell. 1997. Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation. J Am Vet Med Assoc 210:778–784.
686 Thompson, J.P., N. Ackerman, J.R. Bellah, et al. 1992. 192iridium brachytherapy, using an intracavitary afterload device, for treatment of intranasal neoplasms in dogs. Am J Vet Res 53:617–622.
687 Thompson, J.P. and M.J. Fugent. 1992. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979–1990). J Am Vet Med Assoc 200:531–533.
688 Thompson, J.J., D.L. Pearl, J.A. Yager, et al. 2011a. Canine subcutaneous mast cell tumor: Characterization and prognostic indices. Vet Pathol 48:156–168.
689 Thompson, J.J., J.A. Yager, S.J. Best, et al. 2011b. Canine subcutaneous mast cell tumors: Cellular proliferation and Kit expression as prognostic indices. Vet Pathol 48:169–181.
690 Thomson, M.J., S.J. Withrow, W.S. Dernell, et al. 1999. Intermuscular lipomas of the thigh region in dogs: 11 cases. J Am Anim Hosp Assoc 35:165–167.
691 Thrall, D.E. 1981. Orthovoltage radiotherapy of oral fibrosarcomas in dogs. J Am Vet Med Assoc 179:159–162.
692 Thrall, D.E., S.J. Withrow, B.E. Powers, et al. 1990. Radiotherapy prior to cortical allograft limb sparing in dogs with osteosarcoma: A dose response assay. Int J Radiat Oncol Biol Phys 18:1351–1357.
693 Tilmant, L.L., N.T. Gorman, N. Ackerman, et al. 1986. Chemotherapy of synovial cell sarcoma in a dog. J Am Vet Med Assoc 188:530–532.
694 Tobin, R.L., R.W. Nelson, M.D. Lucroy, et al. 1999. Outcome of surgical versus medical treatment of dogs with beta cell neoplasia: 39 cases (1990–1997). J Am Vet Med Assoc 215:226–230.
695 Tomamassini, M., N. Ehrhart, A. Ferretti, et al. 2000. Bone transport osteogenesis for limb salvage following resection of primary bone tumors: Experience with 6 cases (1991–1996). Vet Comp Orthop Trauma 23:43–51.
696 Tomlin, J.L., C. Sturgeon, M.J. Pead, et al. 2000. Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs. Vet Rec 147:129–132.
697 Tran, C.M., A.S. Moore, and A.E. Frimberger. 2016. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy. Vet Comp Oncol 14(3):252–262.
698 Trepanier, L.A. 2007. Pharmacologic management of feline hyperthyroidism. Vet Clin North Am Small Anim Pract 37:775–788, vii.
699 Trepanier, L.A., S.B. Hoffman, M. Kroll, et al. 2003. Efficacy and safety of once versus twice daily administration of methimazole in cats with hyperthyroidism. J Am Vet Med Assoc 222:954–958.
700 Tripp, C.D., J. Fidel, C.L. Anderson, et al. 2011. Tolerability of metronomic administration of lomustine in dogs with cancer. J Vet Intern Med 25:278–284.
701 Trout, N.J., M.M. Pavletic, and K.H. Kraus. 1995. Partial scapulectomy for management of sarcomas in three dogs and two cats. J Am Vet Med Assoc 207:585–587.
702 Tuohy, J.L., L.E. Selmic, D.R. Worley, et al. 2014. Outcome following curative‐intent surgery for oral melanoma in dogs: 70 cases (1998–2011). J Am Vet Med Assoc 245:1266–1273.
703 Tuohy, J.L., D.R. Worley, and S.J. Withrow. 2012. Outcome following simultaneous bilateral thyroid lobectomy for treatment of thyroid gland carcinoma in dogs: 15 cases (1994–2010). J Am Vet Med Assoc 241:95–103.
704 Turek, M.M., L.J. Forrest, W.M. Adams, et al. 2003. Postoperative radiotherapy